TABLE 3.
Penicillium roqueforti
|
Escherichia coli | |||
10% | 20% | 30% | ||
Wet biomass | ||||
WB | 0.0 ± 0.0f | 12.9 ± 0.41e | 13.2 ± 0.47e | + |
WBA | 13.4 ± 0.51d | 12.8 ± 0.44e | 13.1 ± 0.44e | ++ |
WBF | 13.5 ± 0.50d | 13.0 ± 0.52e | 13.3 ± 0.51e | +++ |
WBAF | 13.5 ± 0.44d | 13.1 ± 0.49e | 30.4 ± 1.01c | +++ |
Dried biomass | ||||
DB | 4.3 ± 0.17e | 13.0 ± 0.43e | 21.7 ± 0.86d | − |
DBA | 26.1 ± 1.02c | 21.7 ± 0.91d | 21.6 ± 0.88d | ± |
DBF | 13.0 ± 0.49d | 13.2 ± 0.43e | 13.2 ± 0.54e | + |
DBAF | 13.6 ± 0.46d | 13.4 ± 0.41e | 13.1 ± 0.53e | ± |
Lyophilized biomass | ||||
LB | 13.1 ± 0.51d | 26.2 ± 0.84c | 8.7 ± 0.23f | ± |
LBA | 34.8 ± 1.32b | 34.8 ± 1.36b | 100.0 ± 2.29a | + |
LBF | 34.7 ± 1.36b | 21.9 ± 0.78d | 34.8 ± 1.09c | +++ |
LBAF | 43.5 ± 1.71a | 47.8 ± 1.03a | 56.5 ± 1.18b | +++ |
Data are the means of three independent analyses. a–fValues in the same column with different superscript letters differ significantly (P < 0.05). All biomasses were also treated with Alcalase® (A, 1% vol/wt), fermented with Lactiplantibacillus plantarum T0A10 (F, final cell density of circa 7 log10 cfu/g), or fermented and treated with Alcalase® (AF). Enzymatic and microbial treatments were carried out at 30°C for 24 h. Antifungal activity was determined by hyphal radial growth inhibition of Penicillium roqueforti DPPMAF1 after 6 days of incubation at 25°C in PDA containing 30% vol/vol of the extract. Inhibitory activity against gastrointestinal pathogen Escherichia coli was scored as follows: −, no inhibition; ±, inhibition halo of 1–2 mm; +, inhibition halo of 3–4 mm; ++, inhibition halo of 5–6 mm; +++, inhibition halo of 7–9 mm.